Cleveland Clinic London’s Post

One Call, 100,000+ Medical Imaging Parts Starting February 5th, simplify your search for MRI, CT, and many other imaging parts. Technical Prospects becomes DirectMed Imaging, and you can now access more parts with one call. Benefits for you: ● Access a comprehensive inventory from one source. ● Reduce time spent on multiple inquiries and get your systems scanning sooner. ● 100,000+ Parts: MRI, CT, Angiography (ANGIO), Positron Emission Tomography (PET), Fluoroscopy (FLUORO), Mammography (MAMMO), Radiography (RAD), Ultrasound (ULT), Urology (URO) Single point of contact for all your imaging part needs, making your sourcing more efficient. https://hubs.li/Q02hD0Qv0 or (855) 463-3727. Double the expertise, one comprehensive brand. Technical Prospects will become DirectMed Imaging on February 5th.

Dear researchers, We look forward to your participation in a compelling collection of articles that will advance the field of MIS in urology. Purpose and Welcomed Topics This Special Issue seeks to compile cutting-edge research and comprehensive reviews on the aforementioned innovations and their impact on MIS in urology. We welcome submissions on a variety of topics, including, but not limited to, the following: AI applications in urological diagnostics and surgery; The role of VR and the metaverse in surgical training and planning; Innovations in robotic-assisted urological procedures; Advances in endoscopic technologies and instrumentation; Automation and its impact on surgical workflows; Patient outcomes and experiences with MIS; Future trends and challenges in MIS; Ethical and regulatory considerations in adopting new technologies; Telesurgery and its applications in urology. We invite you to share your valuable insights and contribute to this Special Issue. Please submit your manuscripts by the Special Issue Deadline. https://lnkd.in/dbs69aMr

Through the close collaboration of neurosurgery and mechanical engineering, a joint team from #CUHK and The University of Hong Kong has co-developed the world’s first magnetic resonance imaging (#MRI)-guided intraoperative robot for bilateral stereotactic neurosurgery, facilitating more accurate and effective treatment of Parkinson’s disease, brain tumours and neuropsychiatric disorders. The system was validated through cadaver studies and skull model testing. Initial results have laid a solid foundation for future clinical applications, and have been published in leading international journal #AdvancedScience. This interdisciplinary brainchild is ready to be tested for clinical translation. The first intraoperative MRI (iMRI) system in Hong Kong will come into service at Tuen Mun Hospital in the third quarter of 2024. Two or three more #iMRI systems will be set up in Hong Kong in the coming five years. Read more to learn about the serendipitous synergy for scientific breakthroughs: https://bit.ly/3z98xuK CUHK Medicine #CUHK #TheChineseUniversityofHongKong #TheUniversityofHongKong #CUHKresearch #cuhkinfocus

Can’t wait for our conversation about our THREE #SurgicalAI papers in @npjdigitalmedicine!

There can be challenges to learning the latest techniques for Minimally Invasive Partial Nephrectomy. To learn more, watch the UROTRAINER Virtual Master Class, endorsed by SIU, available now, open access. Global urology leaders Drs Mallikarjuna Chiruvella, Ruben Olivares, and Gonzalo Vitagliano share a review of clinical practices and technical advances in laparoscopic and robotic partial #nephrectomy. Discover more about: 💥 Current status of laparoscopic partial nephrectomy 💥 Robotic partial nephrectomy techniques and new approaches 💥 Adequation of teaching strategies for minimally invasive partial nephrectomy, how do we teach? Watch today on #SIUAcademy, https://bit.ly/4dkSWXT #Laparoscopy #RoboticSurgery 🌐🔬

🎉Celebrating a Milestone! Brain Navi Biotechnology Co., Ltd. achieves a significant feat with its 100th surgical procedure using the advanced neurosurgical navigation robot, NaoTrac. 🤖💡 Dr. Hao-Yu Chuang, Director at Annan Hospital, Tainan, Taiwan, performed this landmark surgery, highlighting NaoTrac's unique ability to register cranial anatomy accurately. Dr. Jerry (Chieh Hsiao) Chen, Brain Navi's CEO, expressed delight in the success and anticipated international outreach in 2024, aiming to bring NaoTrac's transformative technology to more hospitals globally. Read more: https://lnkd.in/g8Ezt93P Follow #Globalbio for updates! 🌐 #BrainNavi #NaoTrac #MedicalInnovation 🚀

Japan Cardiac Surgery Instruments Market: Leading the Way in Cardiac Care 🏥 https://lnkd.in/g6SejsEn Key Highlights: Market Growth: The Japanese market for cardiac surgery instruments is poised for robust growth, driven by an aging population and increasing prevalence of cardiovascular diseases. Technological Innovation: Advances in minimally invasive techniques, robotic-assisted surgery, and high-precision instruments are revolutionizing cardiac surgery. Why It Matters: Cardiovascular diseases remain a leading cause of mortality globally. Innovations in cardiac surgery instruments are critical for improving surgical outcomes, reducing recovery times, and ultimately saving lives. Japan's leadership in this field is contributing significantly to global health advancements. Get Involved: Whether you are a healthcare professional, researcher, or industry stakeholder, your engagement is crucial. Share your insights and experiences on how advanced surgical instruments are transforming cardiac care in Japan. #CardiacSurgery #JapanHealthcare #MedicalInnovation #CardiovascularHealth #SurgicalInstruments #HealthcareAdvancements #LifeSavingTechnology

Time has fascinated the history of humanity since its origins: in particular, preand post-Aristotelian philosophy, Galilean science, Albert Einstein’s theory of relativity, and Enrico Fermi’s quantum physics. The space-time in the theory of relativity is an indissoluble variable - there is no space without time and vice versa. Organ protection from ischemia is a matter of time in relation to the technique; there are many different cardioplegia solutions of varying compositions used for myocardial arrest and protection in cardiac surgery, and the choice of cardioplegia is often up to institution or surgeon preference. In our experience the use of DN solution increases temporarily hemodilution in extracorporeal circulation and is a variable that acts directly on colloid oncotic pressure (COP), determined by all plasma proteins in the intraand extravascular compartments, and plays a key role in transcapillary fluid movement. A decreased COP increases transcapillary fluid movement, which leads to tissue edema and, combined with hemodilution, may compromise peripheral tissues oxygenation and end-organ perfusion. The reduction of hemoglobin content has an impact during CPB on corrective action for red blood cell, hypothermia, and ultrafiltration uses, and it also has an impact on the oxygen delivery (DO₂) - there is ample evidence that an indexed DO₂< 280 ml/min/m2 exposes the patients to postoperative risk and incidence of acute kidney injury (AKI). The use of DN solution for the abovementioned aspects in the MiECC in particular for hemodilution variable appears in contrast, despite the literature being clearly in favor of this methodology in the context of conventional extracorporeal circulation. But there is another aspect we should ask ourselves when choosing myocardial protection solution: 1) Should it be chosen in relation to time according to the surgical technique? 2) Should it be chosen in relation to patient typology and multi-organ preservation during and after CPB? From this point of view, there is no myocardial solution that integrates the answer to these two questions, and consequently the one that meets the benefits and objectives set by MiECC is the BC solution. The literature on minimally invasive cardiac surgery, independently of the myocardial solution used, showed a significant association between cross-clamping time and mortality, low cardiac output syndrome, and AKI, so moving towards a more physiological CPB such as the MiECC is perhaps the most reliable answer.

A recent publication in Science Translational Medicine highlights a new tool aimed at improving the understanding of cerebrovascular issues that lead to strokes.    Researchers have developed a miniature probe that fits within the microcatheters used in brain surgery, providing high-resolution images from inside cerebral arteries. The study involved 32 patients with diverse cerebrovascular conditions, including aneurysms, ischemic strokes, and arterial stenoses.    By providing a clear view from within the vessels, this technology could substantially impact the diagnosis and treatment of cerebrovascular diseases.   #healthtech #innovation #healthcareinnovation